Korsana Biosciences, Inc.
KRSA
Last
$33.92
Day
+1.2%
1y
+93.8%
5y
-92.0%
52w
-43.5%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
31.76
EMA 50
29.78
EMA 200
23.27
20d high
-10.1%
5y high
-93.4%
5y range
5th
Positions held
Your positionsKRSA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
38
Hold
swing
Signal
Strong Buy
Target
$44.05
Stop
$28.24
Stop distance
16.8%
Target vs last
+29.9%
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
Bull case
- Korsana Biosciences operates in the biotechnology sector, which is known for its potential to deliver groundbreaking therapies and innovations, attracting significant investor interest.
- The company's market cap stands at approximately $1.45 billion, indicating a strong presence in the market.
- Korsana has a current ratio of 17.398, suggesting excellent liquidity and the ability to cover short-term obligations.
Bear case
- The company has reported a net income loss of -35.642 million for the year 2025, raising concerns about its profitability.
- Korsana's forward P/E ratio is -8.93, indicating negative earnings expectations from analysts.
- The stock has a price-to-book ratio of -4.05333, suggesting that the market may not value its assets positively.
Fundamentals
| Market cap | $1.53B | Enterprise value | $243.53M | Trailing P/E | — | Forward P/E | -9.42 |
| PEG | — | Price / book | -4.28 | Beta | 1.73 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.01 |
| Current ratio | 17.40 | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $44.00 |
| 52w high | $59.36 | 52w low | $7.19 |
Quarterly
| 2026-Q2 | |
|---|---|
| Revenue | — |
| Op margin | — |
| Net income | — |
| Gross margin | — |
| Gross profit | — |
| Operating income | — |
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $0.0M | $0.0M |
| Op margin | — | — |
| Net income | -$35.6M | -$0.1M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$37.3M | -$0.1M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsKRSA · daily-4.2% over 13 sessions
Close EMA21 EMA50 EMA200